Pulmonx (LUNG) Gross Profit (2019 - 2025)

Pulmonx (LUNG) has 7 years of Gross Profit data on file, last reported at $16.1 million in Q3 2025.

• Gross Profit for Q3 2025 came in at $16.1 million, up 6.83% year-over-year; the trailing twelve-month figure through Sep 2025 was $67.2 million (up 14.24% YoY), and the FY2024 annual result was $62.0 million, up 22.16% from the prior year.
• Gross Profit eased to $16.1 million in Q3 2025 per LUNG's latest filing, from $17.2 million in the prior quarter.
• Over five years, Gross Profit peaked at $17.6 million in Q4 2024 and troughed at $6.6 million in Q1 2021.
• A 5-year average of $12.5 million and a median of $12.7 million in 2023 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2021 and 2022: Gross Profit soared 792.19% in 2021, then increased 4.24% in 2022.
• A 5-year view of Gross Profit shows it stood at $10.3 million in 2021, then advanced by 9.1% to $11.2 million in 2022, then grew by 28.76% to $14.4 million in 2023, then rose by 22.15% to $17.6 million in 2024, then dropped by 8.74% to $16.1 million in 2025.
• Business Quant data shows LUNG's Gross Profit at $16.1 million in Q3 2025, $17.2 million in Q2 2025, and $16.3 million in Q1 2025.